Abbott Laboratories Statistics

Total Valuation

ETR:ABL has a market cap or net worth of EUR 209.46 billion. The enterprise value is 216.42 billion.

Market Cap	209.46B
Enterprise Value	216.42B

Important Dates

The next estimated earnings date is Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.72B

Valuation Ratios

The trailing PE ratio is 16.24.

PE Ratio	16.24
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.16, with an EV/FCF ratio of 35.28.

EV / Earnings	16.78
EV / Sales	5.59
EV / EBITDA	21.16
EV / EBIT	31.27
EV / FCF	35.28

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.32.

Current Ratio	1.67
Quick Ratio	1.05
Debt / Equity	0.32
Debt / EBITDA	1.38
Debt / FCF	2.41
Interest Coverage	13.41

Financial Efficiency

Return on equity (ROE) is 30.91% and return on invested capital (ROIC) is 7.95%.

Return on Equity (ROE)	30.91%
Return on Assets (ROA)	6.06%
Return on Invested Capital (ROIC)	7.95%
Return on Capital Employed (ROCE)	11.15%
Revenue Per Employee	355,434
Profits Per Employee	113,120
Employee Count	114,000
Asset Turnover	0.54
Inventory Turnover	2.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.28% in the last 52 weeks. The beta is 0.69, so ETR:ABL's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+15.28%
50-Day Moving Average	123.10
200-Day Moving Average	108.79
Relative Strength Index (RSI)	49.72
Average Volume (20 Days)	506

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.21

Income Statement

In the last 12 months, ETR:ABL had revenue of EUR 40.52 billion and earned 12.90 billion in profits. Earnings per share was 7.38.

Revenue	40.52B
Gross Profit	22.51B
Operating Income	7.24B
Pretax Income	6.77B
Net Income	12.90B
EBITDA	10.35B
EBIT	7.24B
Earnings Per Share (EPS)	7.38

Full Income Statement

Balance Sheet

The company has 7.70 billion in cash and 14.75 billion in debt, giving a net cash position of -7.06 billion.

Cash & Cash Equivalents	7.70B
Total Debt	14.75B
Net Cash	-7.06B
Net Cash Per Share	n/a
Equity (Book Value)	46.27B
Book Value Per Share	26.59
Working Capital	9.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.27 billion and capital expenditures -2.13 billion, giving a free cash flow of 6.13 billion.

Operating Cash Flow	8.27B
Capital Expenditures	-2.13B
Free Cash Flow	6.13B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.56%, with operating and profit margins of 17.87% and 31.95%.

Gross Margin	55.56%
Operating Margin	17.87%
Pretax Margin	16.72%
Profit Margin	31.95%
EBITDA Margin	25.54%
EBIT Margin	17.87%
FCF Margin	15.14%

Dividends & Yields

This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.73%.

Dividend Per Share	2.10
Dividend Yield	1.73%
Dividend Growth (YoY)	9.96%
Years of Dividend Growth	6
Payout Ratio	28.62%
Buyback Yield	0.06%
Shareholder Yield	1.79%
Earnings Yield	6.16%
FCF Yield	2.93%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:ABL has an Altman Z-Score of 5.24.

Altman Z-Score	5.24
Piotroski F-Score	n/a